Balance wanting low prices for generics but also wanting enough competitors in the market.

The Indian pharmaceutical industry has become almost synonymous with the US regulatory authorities. The Indian firms that have slowly expanded their market share in the generics segment have been facing…

This Teenager is Humanitarian Extraordinaire, has a Healing Hobby

New Delhi: It is not his age to do what he is doing – aggregating free medicines from donors and ensuring they reach the needy patients. While his peers revel…

The global dry eye syndrome treatment market accounted for USD 3.42 billion in 2016 growing at a CAGR of 6.9% during the forecast period of 2017 to 2024.

Dry eye syndrome treatment research report 2019 is a comprehensive, professional report delivering market research data that is relevant for new market entrants or established players. The research study covers…

Investor eyes on launch of the Indian pharma industry new drugs in the US

Nine Masts Capital Ltd increased its stake in United Parcel Service Inc (Put) (UPS) by 9900% based on its latest 2018Q4 regulatory filing with the SEC. Nine Masts Capital Ltd…

Death of a Tobacco Titan and his ‘life’ after death

New Delhi: May soul of Y. C. Deveshwar, ITC’s late Chairman ‘Rest in peace (RIP).’ But will he, if there is life after death? In case there is, his wife…

Journalist Katherine Eben’s book ‘Bottle of Lies’ puts Indian drug companies in the dock

‘Bottle of Lies’ opens a can of worms for Indian drug companies. The new book by Katherine Eban, called an “invaluable exposé” by The New York Times, alleges severe cases…

Quality @reasonable Price is the sine qua non of Taiwan Healthcare Products

New Delhi: Quality at par with USA and European countries but at lower price was what Taiwan flaunted as strength of its healthcare products in Taiwan Expo at Pragati Maidan.…

Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US

A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…

In April MF Invested In IT, Pharma And Telecom

In the absence of earnings growth triggers, which has shrunk the universe of investible ideas, leading fund houses have resorted to selling more of a part of their portfolios than…

The sea lamprey could help scientists develop more effective treatments for brain diseases such as cancer, Alzheimer’s, trauma and stroke.

The blood-brain barrier normally blocks many types of drugs from entering the central nervous system, making it hard to treat brain disorders. Scientists from the University of Wisconsin-Madison and the University…